2015
DOI: 10.3386/w21666
|View full text |Cite
|
Sign up to set email alerts
|

How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome

Abstract: for excellent research assistance. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research. NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official NBER publications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
161
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 100 publications
(170 citation statements)
references
References 49 publications
6
161
3
Order By: Relevance
“…In order to estimate the causal relationship, we use variation in leniency across patent examiners as a source of exogenous variation in granted patents. Patent examiner leniency has been recently used as an instrumental variable to estimate the effect of patents on subsequent cumulative innovation (Sampat and Williams, 2015) and on venture capitalbacked startup success (Gaulé, 2015;Farre-Mensa et al, 2017). The validity of this instrument is supported by interviews with employees of the United States Patent and Trademark Office (USPTO) regarding the allocation of patent applications to examiners (Cockburn et al, 2003;Lemley and Sampat, 2012), as well as by our own exogeneity tests.…”
Section: Introductionmentioning
confidence: 98%
See 3 more Smart Citations
“…In order to estimate the causal relationship, we use variation in leniency across patent examiners as a source of exogenous variation in granted patents. Patent examiner leniency has been recently used as an instrumental variable to estimate the effect of patents on subsequent cumulative innovation (Sampat and Williams, 2015) and on venture capitalbacked startup success (Gaulé, 2015;Farre-Mensa et al, 2017). The validity of this instrument is supported by interviews with employees of the United States Patent and Trademark Office (USPTO) regarding the allocation of patent applications to examiners (Cockburn et al, 2003;Lemley and Sampat, 2012), as well as by our own exogeneity tests.…”
Section: Introductionmentioning
confidence: 98%
“…This instrument was first proposed by Sampat and Williams (2015) based on the work of Lemley and Sampat (2012) and Cockburn et al (2003) on the processes and outcomes of patent examination at the USPTO. We next describe this process to illustrate the rationale for the instrument.…”
Section: Identification Strategymentioning
confidence: 99%
See 2 more Smart Citations
“…3 While our study looks mainly at patents in the electronics and computer industry, Sampat and Williams (2015) consider gene patents and find no effect on follow-on research. The size of our measured effects is consistent with that reported by other studies such as Murray and Stern (2007) and Moser and Voena (2012).…”
Section: Introductionmentioning
confidence: 99%